Renal allograft survival in transplant recipients with focal segmental glomerulosclerosis

American Journal of Transplantation

Volumn 3, Issue 1, 2003, Pages 64-67

  Cibrik, Diane M ^a   Kaplan, Bruce ^c   Campbell, Darrell A ^b   Kriesche, Herwig Ulf Meier ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

6 Antigen match; FSGS; Graft survival; Living donor; Renal transplantation; Zero mismatch

Indexed keywords

HLA ANTIGEN;

ADULT; ARTICLE; CADAVER DONOR; FOCAL GLOMERULOSCLEROSIS; GRAFT SURVIVAL; HLA SYSTEM; HUMAN; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; LIVING DONOR; MAJOR CLINICAL STUDY; RECIPIENT; RECURRENCE RISK; RISK FACTOR;

GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0037221381     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2003.30111.x     Document Type: Article

References (16)

1. Orth SR, Ritz E. The nephrotic syndrome. N Engl J Med 1998; 338: 1202-1211.
2. Savin VJ, Sharma R, Sharma M et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996; 334: 878-883.
3. Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F. Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med 1992; 92: 375-383.
4. Banfi G, Colturi C, Montagnino G, Ponticelli C. The recurrence of focal segmental glomerulosclerosis in kidney transplant patients treated with cyclosporine. Transplantation 1990; 50: 594-596.
5. Hariharan S, Adams MB, Brennan DC et al. Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). Transplantation 1999; 68: 635-641.
6. Feld SM, Figueroa P, Savin V et al. Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys. Am J Kidney Dis 1998; 32: 230-237.
7. First MR. Living-related donor transplants should be performed with caution in patients with focal segmental glomerulosclerosis. Pediatr Nephrol 1995; 9 (Suppl.): S40-S42.
8. Zimmerman CE. Renal transplantation for focal segmental glomerulosclerosis. Transplantation 1980; 29: 172.
9. Morzycka M, Croker BP Jr, Siegler HF, Tisher CC. Evaluation of recurrent glomerulonephritis in kidney allografts. Am J Med 1982; 72: 588-598.
10. Al-Akash SI, Ettenger RB. Kidney transplantation in children. In: Danovitch GM, ed. Handbook of Kidney Transplantation. Philadelphia: Lippincott Williams & Wilkins, 2001: 340.
11. Sayegh MH, Kaplan AA. Focal Glomerulosclerosis: Recurrence After Transplantation. Rose BD, ed. Up-to-date [Version 8.3]. UpToDate Inc., 2000.
12. Baum MA, Stablein DM, Panzarino VM et al. Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis. Kidney Int 2001; 59: 328-333.
13. Abbott KC, Sawyers ES, Oliver JD et al. Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis 2001; 37: 366-373.
14. Cecka JM. The UNOS Scientific Renal Transplant Registry. In: Cecka JM, Terasaki PI. Clinical Transplants. Los Angeles: UCLA Immunogenetics Center, 1999: 1-21.
15. Meier-Kriesche HU, Ojo AO, Cibrik DM et al. Relationship of recipient age and development of chronic allograft failure. Transplantation 2000; 70: 306-310.
16. Meier-Kriesche HU, Ojo AO, Leichtman AB et al. Interaction of mycophenolate mofetil and HLA matching on renal allograft survival. Transplantation 2001; 71: 398-401.